Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration

Shelley L. Forrest, Daniel R. Crockford, Anastasia Sizemova, Heather McCann, Claire E. Shepherd, Andrew B. McGeachie, Andrew J. Affleck, Francine Carew-Jones, Lauren Bartley, John B. Kwok, Woojin Scott Kim, Eve Jary, Rachel H. Tan, Ciara V. McGinley, Olivier Piguet, John R. Hodges, Jillian J. Kril, Glenda M. Halliday

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Objective: To investigate the prevalence of clinically relevant multiple system atrophy (MSA) and Lewy body disease (LBD) pathologies in a large frontotemporal lobar degeneration (FTLD) cohort to determine if concomitant pathologies underlie the heterogeneity of clinical features. 

Methods: All prospectively followed FTLD-tau and FTLD-TDP cases held by the Sydney Brain Bank (n = 126) were screened for coexisting MSA and LBD (Braak ≥ stage IV) pathology. Relevant clinical (including family history) and genetic associations were determined. 

Results: MSA pathology was not identified in this series. Of the FTLD cohort, 9 cases had coexisting LBD ≥ Braak stage IV and were associated with different FTLD subtypes including Pick disease (n = 2), corticobasal degeneration (n = 2), progressive supranuclear palsy (n = 2), and TDP type A (n = 3). All FTLD-TDP cases with coexisting LBD had mutations in progranulin (n = 2) or an abnormal repeat expansion in C9orf72 (n = 1). All FTLD-tau cases with coexisting LBD were sporadic. The H1H1 MAPT haplotype was found in all cases that could be genotyped (n = 6 of 9). Seven cases presented with a predominant dementia disorder, 3 of which developed parkinsonism. Two cases presented with a movement disorder and developed dementia in their disease course. The age at symptom onset (62 ± 11 years) and disease duration (8 ± 5 years) in FTLD cases with coexisting LBD did not differ from pure FTLD or pure LBD cases in the brain bank. 

Conclusion: Coexisting LBD in FTLD comprises a small proportion of cases but has implications for clinical and neuropathologic diagnoses and the identification of biomarkers.

Original languageEnglish
Pages (from-to)e2472-e2482
Number of pages11
JournalNeurology
Volume92
Issue number21
DOIs
Publication statusPublished - 21 May 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration'. Together they form a unique fingerprint.

Cite this